Extrahepatic targeting
WebSep 17, 2024 · Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines Takashi Nakamura, Yusuke Sato, Yuma Yamada, Mahmoud M. Abd Elwakil, ... Hideyoshi Harashima September 2024 Article 114417 Download PDF Article preview
Extrahepatic targeting
Did you know?
WebJul 1, 2024 · @article{Nakamura2024ExtrahepaticTO, title={Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines.}, author={Takashi Nakamura and Yusuke Sato and Yuma Yamada and Mahmoud M. Abd Elwakil and Seigo Kimura and Mahmoud A. Younis and Hideyoshi Harashima}, journal={Advanced drug … WebFeb 21, 2024 · Extrahepatic targeting remains challenging, but promising results for tumour cell delivery and indications beyond are becoming apparent. Beyond this, novel approaches combining cell-specific targeting with endosomal escape enhancement have recently emerged and are rapidly advancing through pre-clinical evaluation.
WebJun 1, 2024 · The use of such novel protein scaffolds, including designed ankyrin repeat proteins (DARPins), for oligonucleotide delivery is attractive for achieving effective tissue targeting. Issues for further development and optimization to advance approaches for extrahepatic oligonucleotide delivery by nanoparticles or bioconjugates are discussed. … WebExtrahepatic bile duct cancer is a rare disease in which cancer cells form in the ducts that are outside the liver. The extrahepatic bile duct is made up of two parts: The common hepatic duct, which is also called the perihilar …
WebFeb 21, 2024 · Extrahepatic targeting remains challenging, but promising results for tumour cell delivery and indications beyond are becoming apparent. Beyond this, novel … WebIn this review, we summarize the possibility and expectations for the extrahepatic delivery of small interfering RNA/messenger RNA/plasmid DNA/genome editing to the spleen, …
WebMar 10, 2024 · Abstract Therapeutic nucleic acids hold immense potential in combating undruggable, gene-based diseases owing to their high programmability and relative ease of synthesis. While the delivery of this class of therapeutics has successfully entered the clinical setting, extrahepatic targeting, endosomal escape efficiency, and subcellular …
Webextrahepatic. (ĕk′strə-hĭ-păt′ĭk) adj. Originating or occurring outside the liver. The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. … bricktown gospel fellowshipWebMay 7, 2024 · Extrahepatic delivery of small interfering RNAs (siRNAs) may have applications in the development of novel therapeutic approaches. However, reports on … bricktown event centerWebAug 5, 2024 · By targeting the liver-specific glycogen synthase GYS2 with a GalNAc-siRNA conjugate, ... While most ligand-based approaches are utilizing GalNAc for delivery, other ligand-based delivery systems targeting oligonucleotides to extrahepatic tissues are emerging. For example, a GLP1R agonist peptide has been shown to effectively target … bricktown events centerWebTargeting extrahepatic tissues is the key next step for lipid-based delivery to continue maximizing therapeutic potential and allowing treatment of unmet patient needs. However, due to trafficking to and accumulation in the liver, this is easier said than done. Join this workshop to hear: bricktowne signature villageWebJun 2, 2024 · Here, we combine two technologies to achieve posttranscriptional gene silencing in tumor cells: Centyrins, alternative scaffold proteins binding plasma membrane receptors for targeted delivery, and small interfering RNAs (siRNAs), chemically modified for high metabolic stability and potency. bricktown filmsWebJan 19, 2024 · However, current delivery technologies in the clinic largely target the liver, and extrahepatic delivery remains a bottleneck for realizing the full potential of siRNA. … bricktown entertainment oklahoma cityWebMar 10, 2024 · Therapeutic nucleic acids hold immense potential in combating undruggable, gene-based diseases owing to their high programmability and relative ease of synthesis. While the delivery of this class of therapeutics has successfully entered the clinical setting, extrahepatic targeting, endosomal escape efficiency, and subcellular localization … bricktown fort smith